Gestational Diabetes Mellitus Is Strongly Associated With Non-Alcoholic Fatty Liver Disease
- PMID: 27002796
- PMCID: PMC4860097
- DOI: 10.1038/ajg.2016.57
Gestational Diabetes Mellitus Is Strongly Associated With Non-Alcoholic Fatty Liver Disease
Abstract
Objectives: Insulin resistance is central to the development of non-alcoholic fatty liver disease (NAFLD), and gestational diabetes mellitus (GDM) is an early marker of insulin resistance. We hypothesized that a history of GDM would identify women at higher risk of NAFLD in middle age.
Methods: Women from the multicenter Coronary Artery Risk Development in Young Adults (CARDIA) cohort study who delivered ≥1 birth, were free of diabetes prior to pregnancy(ies), and underwent CT quantification of hepatic steatosis 25 years following cohort entry (Y25: 2010-2011) were included (n=1,115). History of GDM by self-report, validated in a subsample by review of antenatal glucose testing, and metabolic risk factors were assessed prospectively. NAFLD was defined by liver attenuation (LA)≤40 Hounsfield Units on CT scan after exclusion of other causes of hepatic steatosis.
Results: Of 1,115 women meeting selection criteria (57% black, 43% white, median age 25 years at baseline), 124 (11%) reported a history of GDM and 75 (7%) met the CT definition for NAFLD at year 25. The crude risk of NAFLD at the 25-year visit was significantly higher in women with GDM compared to those without (14 vs. 5.8%, OR: 2.56, 95% CI: 1.44-4.55, P<0.01). History of GDM remained associated with NAFLD (OR: 2.29, 95% CI: 1.23-4.27, P=0.01) after adjustment for covariates in multivariable logistic regression. Addition of incident diabetes mellitus (DM) into the final model attenuated the association between GDM and NAFLD (OR: 1.48, 95% CI: 0.73-3.02, P=0.28).
Conclusion: GDM is a risk marker for NAFLD and represents an opportunity to identify women at risk for NAFLD at a young age and may be mediated by the development of incident DM.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4860097/bin/nihms781745f1.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4860097/bin/nihms781745f2.gif)
Similar articles
-
The prevalence of gestational diabetes mellitus in women diagnosed with non-alcoholic fatty liver disease during pregnancy: A systematic review and meta-analysis.J Diabetes Complications. 2021 Sep;35(9):107991. doi: 10.1016/j.jdiacomp.2021.107991. Epub 2021 Jun 27. J Diabetes Complications. 2021. PMID: 34219018 Review.
-
Prevalence of non-alcoholic fatty liver disease and factors associated with it in Indian women with a history of gestational diabetes mellitus.J Diabetes Investig. 2021 May;12(5):877-885. doi: 10.1111/jdi.13411. Epub 2020 Oct 26. J Diabetes Investig. 2021. PMID: 32961610 Free PMC article.
-
Increased risk of non-alcoholic fatty liver disease in women with gestational diabetes mellitus: A population-based cohort study, systematic review and meta-analysis.J Diabetes Complications. 2019 Oct;33(10):107401. doi: 10.1016/j.jdiacomp.2019.06.006. Epub 2019 Jun 27. J Diabetes Complications. 2019. PMID: 31326267
-
Non-alcoholic fatty liver disease in the first trimester and subsequent development of gestational diabetes mellitus.Diabetologia. 2019 Feb;62(2):238-248. doi: 10.1007/s00125-018-4779-8. Epub 2018 Nov 23. Diabetologia. 2019. PMID: 30470912
-
Longer lactation duration is associated with decreased prevalence of non-alcoholic fatty liver disease in women.J Hepatol. 2019 Jan;70(1):126-132. doi: 10.1016/j.jhep.2018.09.013. Epub 2018 Nov 1. J Hepatol. 2019. PMID: 30392752 Free PMC article.
Cited by
-
Gestational diabetes mellitus and development of intergenerational non-alcoholic fatty liver disease (NAFLD) after delivery: a systematic review and meta-analysis.EClinicalMedicine. 2024 Apr 29;72:102609. doi: 10.1016/j.eclinm.2024.102609. eCollection 2024 Jun. EClinicalMedicine. 2024. PMID: 38707911 Free PMC article.
-
Non-alcoholic fatty liver disease and gestational diabetes mellitus: a bidirectional two-sample mendelian randomization study.BMC Endocr Disord. 2024 Mar 20;24(1):40. doi: 10.1186/s12902-024-01569-6. BMC Endocr Disord. 2024. PMID: 38504196 Free PMC article.
-
Gestational diabetes mellitus and risk of long-term all-cause and cardiac mortality: a prospective cohort study.Cardiovasc Diabetol. 2024 Feb 1;23(1):47. doi: 10.1186/s12933-024-02131-3. Cardiovasc Diabetol. 2024. PMID: 38302966 Free PMC article.
-
The role of lipid dysregulation in gestational diabetes mellitus: Early prediction and postpartum prognosis.J Diabetes Investig. 2024 Jan;15(1):15-25. doi: 10.1111/jdi.14119. Epub 2023 Dec 14. J Diabetes Investig. 2024. PMID: 38095269 Free PMC article. Review.
-
Synergistic effect of non-alcoholic fatty liver disease and history of gestational diabetes to increase risk of type 2 diabetes.Eur J Epidemiol. 2023 Aug;38(8):901-911. doi: 10.1007/s10654-023-01016-1. Epub 2023 May 31. Eur J Epidemiol. 2023. PMID: 37253998
References
-
- Williams CD, Stengel J, Asike MI, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011;140:124–31. - PubMed
-
- Charlton MR, Burns JM, Pedersen RA, Watt KD, Heimbach JK, Dierkhising RA. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology. 2011;141:1249–53. - PubMed
-
- Baffy G, Brunt EM, Caldwell SH. Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. Journal of hepatology. 2012;56:1384–91. - PubMed
-
- Herrera E. Metabolic adaptations in pregnancy and their implications for the availability of substrates to the fetus. European journal of clinical nutrition. 2000;54(Suppl 1):S47–51. - PubMed
Publication types
MeSH terms
Grants and funding
- R01 DK090047/DK/NIDDK NIH HHS/United States
- HHSN268201300026C/HL/NHLBI NIH HHS/United States
- P30 DK026743/DK/NIDDK NIH HHS/United States
- R01 DK106201/DK/NIDDK NIH HHS/United States
- P30 DK079626/DK/NIDDK NIH HHS/United States
- HHSN268201300025C/HL/NHLBI NIH HHS/United States
- T32 DK060414/DK/NIDDK NIH HHS/United States
- HHSN268201300027C/HL/NHLBI NIH HHS/United States
- R01 HL098445/HL/NHLBI NIH HHS/United States
- HHSN268201300029C/HL/NHLBI NIH HHS/United States
- K01 DK059944/DK/NIDDK NIH HHS/United States
- UL1 TR001422/TR/NCATS NIH HHS/United States
- HHSN268200900041C/HL/NHLBI NIH HHS/United States
- HHSN268201300028C/HL/NHLBI NIH HHS/United States
- KL2 TR001424/TR/NCATS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous